You are here
The Mental Health Phase of Care (MHPoC) Clinical Refinement Testing Project aimed to determine whether refinements to the MHPoC recommended as part of the 2017 Clinical Refinement Project improved the reliability of how MHPoC definitions are applied by clinicians. This report outlines the findings from the testing and recommendations on the future refinement of the MHPoC. This report was approved by the Pricing Authority in May 2021.
IHPA is responsible for relevant data collections to enable activity based funding. IHPA’s Data Access and Release Policy outlines the principles and processes adopted by IHPA in the discretionary access and release of data collected under the National Health Reform Act 2011. The Policy provides guidance as to how IHPA will determine whether to release data.
Each year, IHPA publishes the General List of In-Scope Public Hospital Services (the General List) as part of the National Efficient Price Determination.
The General List defines public hospital services eligible for Commonwealth funding, except where funding is otherwise agreed between the Commonwealth and a state or territory.
Following the completion of the 2016 Inter-Rater Reliability (IRR) study to test the consistency of clinician application of the mental health phase of care, the poor to fair reliability outcome led to the commencement of the refinement project.
The Independent Hospital Pricing Authority (IHPA) has developed the Australian Mental Health Care Classification Pricing Feasibility Report 2020–21 to provide an overview of the process undertaken by IHPA to shadow price admitted mental health services using the Australian Mental Health Care Classification (AMHCC) Version 1.0.
The Independent Hospital Pricing Authority (IHPA) is established under the National Health Reform Act 2011 (Cwlth) (the Act), and by virtue of section 131(1) of the Act is invested with the following functions relevant to this National Efficient Cost Determination 2020–21 (Determination):
The Independent Hospital Pricing Authority (Pricing Authority) is established under the National Health Reform Act 2011 (Cth) (the Act), and by virtue of section 131(1) of the Act is invested with the following functions relevant to this National Efficient Cost Determination 2013 (Determination):
(a) to determine the national efficient cost for health care services provided by public hospitals where the services are block funded;